Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
MSB Announcements
Ryoncil Q4 Net Revenue of US$36M and…
MSB
MESOBLAST LIMITED
Market sensitive
Ryoncil Q4 Net Revenue of US$36M and US$115M for Full Year
Date and time
10 July 2026 at 7:57 pm
Announcement type
Periodic Reports
Show details
Hide details
Category
Reports
Report codes
03014
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
MSB announcement history
Recent MSB announcements
Major Milestone Treatment Completed in P3 Trial for CLBP
Becoming a substantial holder
Ceasing to be a substantial holder
Becoming a substantial holder
Ceasing to be a substantial holder
Becoming a substantial holder